NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
CHA University
CHA University
Centre Oscar Lambret
Institute of Oncology Ljubljana